Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 8, Number 5, May 2016, pages 373-378


Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study

Figure

Figure 1.
Figure 1. Outline of the study.

Tables

Table 1. Characteristics of the Patients
 
Characteristics
SD: standard deviation; BMI: body mass index; HbA1c: hemoglobin A1c; NGSP: National Glycohemoglobin Standardization Program; eGFR: estimated glomerular filtration rate.
Number257
Age, mean ± SD53.9 ± 10.4
  < 65 years, n (%)215 (83.7)
  ≥ 65 years, n (%)42 (16.3)
Sex
  Male, n (%)123 (47.9)
  Female, n (%)134 (52.1)
Weight, kg, mean ± SD80.3 ± 17.4
BMI, kg/m2, mean ± SD30.0 ± 5.4
HbA1c, % (NGSP), mean ± SD (n)8.2 ± 1.5 (254)
Fasting glucose, mg/dL, mean ± SD (n)158.5 ± 43.6 (110)
Postprandial glucose, mg/dL, mean ± SD (n)199.1 ± 85.2 (93)
Duration of diabetes, years, mean ± SD (n)9.6 ± 6.9 (248)
Systolic blood pressure, mm Hg, mean ± SD (n)131.3 ± 15.9 (254)
Diastolic blood pressure, mm Hg, mean ± SD (n)78.3 ± 10.6 (254)
eGFR, mL/min/1.73 m2, mean ± SD83.89 ± 21.67
  < 60 mL/min/1.73 m2, n (%)31 (12.3)
  ≥ 60 mL/min/1.73 m2, n (%)222 (87.7)
Drinking alcohol
  Yes, number (%)87 (33.9)
  No, number (%)169 (65.8)
Smoking tobacco
  Yes, number (%)78 (30.4)
  No, number (%)178 (69.3)

 

Table 2. Changes in Parameters Related to Glycemic Control and Body Weight
 
nBaselineWeek 4Week 12
Analysis of variance: vs. baseline *P < 0.01, week 4 vs. week 12 †P < 0.01. HbA1c: hemoglobin A1c; BMI: body mass index.
HbA1c, %2578.237.81*7.55*†
Fasting glucose, mg/dL110158.5139.2*134.6*
Postprandial glucose, mg/dL93199.1161.0*154.9*
Body weight, kg24079.978.8*78.1*†
BMI, kg/m224129.929.5*29.2*†
Waist circumference, cm250101.299.9*99.0*†

 

Table 3. Multiple Regression Analysis of Factors Influencing the Change in HbA1c in Week 12
 
Independent variableStandardized coefficient βPartial regression coefficientP value
n = 243. Stepwise analysis with the following independent variables: age, sex, duration of diabetes, baseline HbA1c, baseline BMI, and treatment category (new monotherapy, concurrent administration, or switching treatment). Dependent variable: decrease in HbA1c. BMI: body mass index; HbA1c: hemoglobin A1c.
Constant02.0500.0034
Age0.0200.0020.7324
Sex0.0810.2030.1196
Duration of diabetes0.2050.0370.0003
BMI (baseline)0.0800.0190.1213
HbA1c (baseline)-0.585-0.485< 0.0001
Switching treatment0.2060.806< 0.0001

 

Table 4. Multiple Regression Analysis of Factors Influencing the Change in Body Weight in Week 12
 
Independent variableStandardized coefficient βPartial regression coefficientP value
n = 238. Stepwise analysis with the following independent variables: age, sex, duration of diabetes, baseline HbA1c, and baseline BMI. Dependent variable: decrease in body weight. BMI: body mass index; HbA1c: hemoglobin A1c.
Constant0-0.1170.9422
Age-0.065-0.0150.3714
Sex-0.092-0.4360.1447
Duration of diabetes0.0510.0180.4502
BMI (baseline)-0.237-0.1110.0002
HbA1c (baseline)0.2150.3340.0005